Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 492 entries
View as:

Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT05141617 Org: User:
Start: 11/03/21 End: 12/31/23 Due: 12/31/24

Federal Learning Algorithm for an Intelligent Insulin Decision System for Dynamic Glucose Control in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT06434623 Org: User:
Start: 09/01/24 End: 06/30/26 Due: 06/30/27

Diagnostic and Prognostic Value of Angiography-derived IMR

Phase: N/A Priority: Normal
NCT ID: NCT04825028 Org: User:
Start: 04/01/21 End: 10/01/21 Due: 10/01/22

Pregabalin Stabilize Cardiovascular Response to Intubation

Phase: N/A Priority: Normal
NCT ID: NCT03456947 Org: User:
Start: 01/01/17 End: 06/30/17 Due: 06/30/18

Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03797729 Org: User:
Start: 05/14/19 End: 12/31/21 Due: 12/31/22

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

Phase: N/A Priority: Normal
NCT ID: NCT06319300 Org: User:
Start: 04/19/24 End: 05/20/26 Due: 05/20/27

Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05185544 Org: User:
Start: 01/01/22 End: 12/31/24 Due: 12/31/25

A Pilot Study in Severe Patients With Takayasu Arteritis.

Phase: N/A Priority: Normal
NCT ID: NCT04300686 Org: User:
Start: 03/01/20 End: 12/31/23 Due: 12/31/24

The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

Phase: N/A Priority: Normal
NCT ID: NCT04605861 Org: User:
Start: 08/18/20 End: 04/15/23 Due: 04/15/24

Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails

Phase: N/A Priority: Normal
NCT ID: NCT02311608 Org: User:
Start: 02/28/14 End: 06/30/16 Due: 06/30/17

Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05333809 Org: User:
Start: 07/01/22 End: 07/01/25 Due: 07/01/26

Comprehensive Functional Assessments for NOCAD

Phase: N/A Priority: Normal
NCT ID: NCT06175572 Org: User:
Start: 01/01/18 End: 12/31/22 Due: 12/31/23

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

Phase: N/A Priority: Normal
NCT ID: NCT04215471 Org: User:
Start: 02/01/20 End: 12/01/22 Due: 12/01/23

Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices

Phase: N/A Priority: Normal
NCT ID: NCT02945930 Org: User:
Start: 09/30/16 End: 11/30/18 Due: 11/30/19

Neoadjuvant Immunochemotherapy for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06023797 Org: User:
Start: 01/31/17 End: 07/31/23 Due: 07/31/24

This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.

Phase: N/A Priority: Normal
NCT ID: NCT05391815 Org: User:
Start: 04/01/21 End: 06/01/32 Due: 06/01/33

Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease

Phase: N/A Priority: Normal
NCT ID: NCT04966767 Org: User:
Start: 08/01/21 End: 12/31/27 Due: 12/31/28

Angiography-derived FFR GPS in Predicting Post-PCI Physiological and Clinical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05496023 Org: User:
Start: 01/01/17 End: 10/01/22 Due: 10/01/23

The Research of the Evaluation of Clinical Procedures in Gastroesophageal Varices in Patients With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01592578 Org: User:
Start: 03/31/12 End: 08/31/13 Due: 08/31/14

Tetracycline Versus Doxycycline for HP Rescue Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05018923 Org: User:
Start: 08/24/21 End: 12/30/22 Due: 12/30/23

Development and Application of Virtual Reality (VR) and Human Computer Interaction System in the ICU Patients

Phase: N/A Priority: Normal
NCT ID: NCT05522400 Org: User:
Start: 05/01/21 End: 12/31/23 Due: 12/31/24

Surgery for Masaoka-Koga I-II Thymoma

Phase: N/A Priority: Normal
NCT ID: NCT05001113 Org: User:
Start: 08/15/21 End: 08/17/22 Due: 08/17/23

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Phase: N/A Priority: Normal
NCT ID: NCT04850157 Org: User:
Start: 04/20/21 End: 12/20/23 Due: 12/20/24

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

Phase: N/A Priority: Normal
NCT ID: NCT06537908 Org: User:
Start: 08/01/24 End: 12/31/29 Due: 12/31/30

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06225622 Org: User:
Start: 03/11/24 End: 05/01/26 Due: 05/01/27